Thursday, December 05, 2013
Go to Market Reports.com
A Scientific Approach to Good Manufacturing Practices
Bile Acids: Beyond Cholesterol Metabolism & Fat Absorption
Carbonylation using carbon monoxide: Novasep’s shortcut to complex str
Expedite Development While Ensuring Successful Commercial Outcomes
Medical Affairs at the Centre of Life Sciences Innovation
NonClinical Dose Formulation Analysis Method Validation and Sample Ana
Product Lifecycle Management: Maximizing profit and leveraging innovat
Vetter Pharma International GmbH
showing results 1 to 9 of 19
Drug Testing without the Pain at Queen’s
Microneedles on a sticking-plaster-like patch may be the painless and safe way doctors will test for drugs and some infections in the future.
£2.25 Million Trial for Vascular Dementia Treatment
Researchers aim to find out if a drug for blood pressure could be effective in treating vascular dementia in a new £2.25million clinical trial.
Protectimmun Gets Positive Scientific Advice Response from EMA for Innovative Allergy Prophylaxis
Protectimmun GmbH has successfully discussed the overall clinical development plan for its innovative allergy prophylaxis against hay fever and allergic asthma.
Malaria Vaccine Offers New Mode of Protection Against Disease
A novel malaria vaccine developed at Oxford University has shown promising results in the first clinical trial.
Researchers Have a Nose for How Probiotics Could Affect Hay Fever
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge.
UK Scientists to Begin Trial of Potential HIV Cure
Scientists and clinicians from five leading UK universities will begin a groundbreaking clinical trial next year to test a possible cure for HIV infection.
Protein Found in Fat-Derived Stem Cells Could Halt Age-Related Retinal Damage
A type of protein found in stem cells taken from adipose (fat) tissue can reverse and prevent age-related, light-induced retinal damage in a mouse model.
Major Breakthrough in the Fight against Antibiotic Resistance
'Resistance breaker’ compounds have been described as the most important innovation in the discovery of new antibiotics since Alexander Fleming’s original breakthrough.
Biologists ID New Cancer Weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
NIH Launches Trial of Investigational Genital Herpes Vaccine
Trial will test an investigational HSV-2 vaccine candidate, called HSV529.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.